At J&J we’re committed to supporting externally sponsored scientific research, which includes Investigator-Initiated Studies (IIS) and collaborative studies, that promote the advancement of medical and scientific knowledge involving J&J’s products and therapeutic areas of interest.

This information is intended for potential investigators
This program is open to all researchers who are interested in conducting their own research. Support may be provided in the form of funding and/or product. Financial and/or product support is contingent upon full execution by both parties of a research agreement.
NOTE: All submissions must be via the website. Email submissions are not accepted.
NOTE: The Johnson & Johnson Innovative Medicine IIS Review Committee requires all application submittals to be made in English.
Each request will go through Johnson & Johnson Innovative Medicine internal review which consists of a cross-functional team composed of personnel from Regulatory, Clinical and Medical Affairs, Statistics, and Health Care Compliance. A decision is based on criteria in the areas of, but not limited to, scientific merit, strategic fit with the evidence generation plan of Johnson & Johnson Innovative Medicine, investigator research experience, and adherence to Good Clinical Practice / Good Laboratory Practice.
You will be notified via e-mail of the decision. If your Research Application is approved you will be asked to submit study documents for final review. These documents include:
Once these documents have been approved and a research agreement has been fully executed, agreed-upon funding and/or product will be released according to the terms in the research agreement.
Compounds with areas of interest for Externally Sponsored Research are listed below. We aren’t accepting proposals at this time for the non-listed compounds.

